一名重型β地中海贫血患者的输血后高溶血综合征
Post-transfusion hyperhemolysis syndrome in a patient with beta thalassemia major.
作者信息
Kasinathan Ganesh, Sathar Jameela
机构信息
Department of Haematology Ampang Hospital Ampang Malaysia.
出版信息
Clin Case Rep. 2021 Jun 22;9(6):e04226. doi: 10.1002/ccr3.4226. eCollection 2021 Jun.
Abstract
Hyperhemolysis syndrome (HS) is characterized by the occurrence of severe anemia with post-transfusion hemoglobin and hematocrit levels being markedly lower than those present prior to transfusion. A high index of suspicion of HS in a multi-transfused thalassemia patient allows prompt institution of therapy resulting in improved survival outcome.
摘要
高溶血综合征（HS）的特征是出现严重贫血，输血后血红蛋白和血细胞比容水平明显低于输血前。对多次输血的地中海贫血患者高度怀疑HS，可促使及时进行治疗，从而改善生存结局。
相似文献
1
Post-transfusion hyperhemolysis syndrome in a patient with beta thalassemia major.一名重型β地中海贫血患者的输血后高溶血综合征
Clin Case Rep. 2021 Jun 22;9(6):e04226. doi: 10.1002/ccr3.4226. eCollection 2021 Jun.
2
An Unusual Case of Hyperhemolysis Syndrome and Delayed Hemolytic Transfusion Reaction due to Anti-Jk(a) and Anti-P1 Antibodies.一例由抗Jk(a)和抗P1抗体引起的高溶血综合征及迟发性溶血性输血反应的罕见病例。
Case Rep Med. 2023 Dec 31;2023:5290115. doi: 10.1155/2023/5290115. eCollection 2023.
3
Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.一名无血红蛋白病患者出现的高溶血综合征，对依库珠单抗治疗无反应。
Transfusion. 2015 Mar;55(3):623-8. doi: 10.1111/trf.12876. Epub 2014 Sep 26.
4
Acute Hyperhemolysis Syndrome in a Patient with Known Sickle Cell Anemia Refractory to Steroids and IVIG Treated with Tocilizumab and Erythropoietin: A Case Report and Review of Literature.一名已知患有镰状细胞贫血的患者出现急性高溶血综合征，对类固醇和静脉注射免疫球蛋白治疗无效，采用托珠单抗和促红细胞生成素治疗：病例报告及文献综述
Hematol Rep. 2022 Jul 21;14(3):235-239. doi: 10.3390/hematolrep14030032.
5
Hyperhemolytic Syndrome Complicating a Delayed Hemolytic Transfusion Reaction due to anti-P1 Alloimmunization, in a Pregnant Woman with HbO-Arab/β-Thalassemia.一名患有血红蛋白O-阿拉伯型/β地中海贫血的孕妇，因抗P1同种免疫引发迟发性溶血性输血反应并发高溶血性综合征。
Mediterr J Hematol Infect Dis. 2016 Oct 18;8(1):e2016053. doi: 10.4084/MJHID.2016.053. eCollection 2016.
6
Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-M Alloantibody in Myelofibrosis: A Case Report.骨髓纤维化中抗-M同种抗体所致延迟性溶血性输血反应伴高溶血综合征：一例报告
Cureus. 2023 Dec 18;15(12):e50717. doi: 10.7759/cureus.50717. eCollection 2023 Dec.
7
Hyperhemolysis syndrome in patients with sickle cell anemia: report of three cases.镰状细胞贫血患者的高溶血综合征：三例报告。
Transfusion. 2015 Jun;55(6 Pt 2):1394-8. doi: 10.1111/trf.12993. Epub 2015 Feb 10.
8
Hyperhemolysis in a patient with beta-thalassemia major.一名重型β地中海贫血患者的高溶血现象。
Asian J Transfus Sci. 2009 Jan;3(1):26-7. doi: 10.4103/0973-6247.45259.
9
Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia.
Ann Hematol. 2016 Sep;95(9):1419-27. doi: 10.1007/s00277-016-2733-8. Epub 2016 Jul 9.
10
An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jk and Anti-Fy Alloantibodies.一例因抗Jk和抗Fy同种抗体导致的伴有高溶血综合征的迟发性溶血性输血反应罕见病例。
J Hematol. 2022 Apr;11(2):66-70. doi: 10.14740/jh968. Epub 2022 Apr 12.
引用本文的文献
1
Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-M Alloantibody in Myelofibrosis: A Case Report.骨髓纤维化中抗-M同种抗体所致延迟性溶血性输血反应伴高溶血综合征：一例报告
Cureus. 2023 Dec 18;15(12):e50717. doi: 10.7759/cureus.50717. eCollection 2023 Dec.
本文引用的文献
1
Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients.依库珠单抗挽救疗法用于镰状细胞病患者的迟发性溶血性输血反应
Blood. 2016 Feb 25;127(8):1062-4. doi: 10.1182/blood-2015-09-669770. Epub 2016 Jan 12.
2
Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.一名无血红蛋白病患者出现的高溶血综合征，对依库珠单抗治疗无反应。
Transfusion. 2015 Mar;55(3):623-8. doi: 10.1111/trf.12876. Epub 2014 Sep 26.
3
Direct antiglobulin ("Coombs") test-negative autoimmune hemolytic anemia: a review.直接抗球蛋白（“库姆斯”）试验阴性的自身免疫性溶血性贫血：综述
Blood Cells Mol Dis. 2014 Apr;52(4):152-60. doi: 10.1016/j.bcmd.2013.12.003. Epub 2014 Jan 9.
4
Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.免疫抑制联合血浆与红细胞置换治疗复发性高红细胞溶解综合征
Transfusion. 2014 Feb;54(2):384-8. doi: 10.1111/trf.12258. Epub 2013 May 21.
5
Hyperhemolysis syndrome complicating pregnancy in homozygous δβ-thalassemia.
Hemoglobin. 2012;36(2):183-5. doi: 10.3109/03630269.2011.649150. Epub 2012 Jan 12.
6
Hyperhemolysis syndrome in sickle cell disease.镰状细胞病中的高溶血综合征
Expert Rev Hematol. 2009 Apr;2(2):111-5. doi: 10.1586/ehm.09.2.
7
Hyperhemolysis in a patient with beta-thalassemia major.一名重型β地中海贫血患者的高溶血现象。
Asian J Transfus Sci. 2009 Jan;3(1):26-7. doi: 10.4103/0973-6247.45259.
8
Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia.利妥昔单抗作为镰状细胞贫血中高溶血综合征的有效治疗方法。
Am J Hematol. 2010 Jan;85(1):91-2. doi: 10.1002/ajh.21578.
9
Guidelines on the use of intravenous immune globulin for hematologic conditions.血液系统疾病静脉注射免疫球蛋白应用指南。
Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S9-56. doi: 10.1016/j.tmrv.2007.01.001.
10
Severe neonatal hemolysis due to a maternal antibody to the low-frequency Rh antigen C(w).
Am J Perinatol. 2006 May;23(4):213-7. doi: 10.1055/s-2006-934098. Epub 2006 Apr 4.
Zotero 插件